Zhang, Lei <br/><br/>
The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.  [electronic resource] 

 -  Laboratory investigation; a journal of technical methods and pathology  Aug 2014 
 - 839-50 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1530-0307 
<br/><br/><label>Standard No.: </label>10.1038/labinvest.2014.69  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aldosterone--chemistry<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Animals<br/>Anti-Inflammatory Agents--therapeutic use<br/>Cilazapril--therapeutic use<br/>Dialysis Solutions--chemistry<br/>Disease Models, Animal<br/>Drug Therapy, Combination<br/>Lymphocytes--drug effects<br/>Macrophages--drug effects<br/>Male<br/>Mineralocorticoid Receptor Antagonists--therapeutic use<br/>Peritoneal Dialysis, Continuous Ambulatory--adverse effects<br/>Peritoneal Fibrosis--etiology<br/>Peritoneum--drug effects<br/>Peritonitis--etiology<br/>Random Allocation<br/>Rats<br/>Rats, Wistar<br/>Receptors, Mineralocorticoid--chemistry<br/>Spironolactone--therapeutic use<br/>Transforming Growth Factor beta1--analysis